Keywords: Drug approvals, Patent cliff, USA, FDA, Fitch Ratings

Global pharmaceutical approvals moderate as patent cliff peaks, says Fitch

Article | 26 July 2012

The Food and Drug Administration will approve fewer novel drugs in 2012 compared to 2011 while the industry faces several ongoing operational ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in